Overweight and obesity: the pathogenesis of cardiometabolic risk (Q84595605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Overweight and obesity: the pathogenesis of cardiometabolic risk (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

George A Bray

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Michael B Clearfield

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Dan J Fintel

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Donald S Nelinson

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

30-40; discussion 41-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Abdominal adiposity and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

The role of adiposity as a determinant of an inflammatory milieu.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Regulation of plasma triglycerides in insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

The importance of treating cardiometabolic risk factors in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Adipokines: molecular links between obesity and atheroslcerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Inflammatory Reactions in the Pathogenesis of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Interleukin-6 induces cellular insulin resistance in hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Adiponectin and adiponectin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Inflammatory mechanisms in the regulation of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

1 reference

7 January 2021

Leptin receptor signaling and action in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Acute stimulation of glucose metabolism in mice by leptin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Does leptin cause vascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Role of resistin in obesity, insulin resistance and Type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Minireview: Adiposity, Inflammation, and Atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Assessment of the obese patient

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

National patterns of physician activities related to obesity management

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Diagnosis of obesity by primary care physicians and impact on obesity management

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes As

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980003-3

7 January 2021

10.1016/S1098-3597(09)80003-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19789062%20AND%20SRC:MED&resulttype=core&format=json